Share ownership Jaguar Health, Inc.

JAGX

US47010C8881

Pharmaceuticals

Delayed Nasdaq Other stock markets 12:33:49 10/07/2025 am IST			5-day change	1st Jan Change
2.620 ^USD	+0.38%		+1.95%	-89.62%

25/06	Jaguar Health to Seek European Regulatory Approval for Dog Diarrhea Treatment	MT
11/06	Jaguar Health Establishes First Site for Canalevia-CA1 Field Study	MT

Share class: Jaguar Health, Inc.

	Vote	Quantity	Free-Float	Total Float
Stock A	0	99	0	81.66 %
Stock B	0	9	0
Stock C	1	1,30,88,288	1,06,87,254 ( 81.66 %)

Major shareholders: Jaguar Health, Inc.

Name	Equities	%	Valuation
Heights Capital Management, Inc. 7.846 %	1,03,912	7.846 %	261 858 $
Intracoastal Capital LLC 4.908 %	65,002	4.908 %	163 805 $
Fredrick Waid 3.857 %	51,084	3.857 %	128 732 $
Streeterville Management LLC 3.434 %	45,478	3.434 %	114 605 $
Iliad Management Ltd. 2.403 %	31,830	2.403 %	80 212 $
Fife Trading, Inc. 1.189 %	15,748	1.189 %	39 685 $
GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI 0.8389 %	11,111	0.8389 %	28 000 $
UBS Securities LLC 0.2365 %	3,132	0.2365 %	7 893 $
UBS Group AG (13f Subfiler) 0.0893 %	1,183	0.0893 %	2 981 $
RBC Dominion Securities, Inc. 0.053 %	702	0.053 %	1 769 $
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Other	12.02%
Institutional	8.14%
Individuals	4%
Gen Ilaç ve Saglik Ürünleri Sanayi ve Ticaret AS	0.84%
Unknown	75%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	17.61%
Individuals	4%
Mauritius	2.4%
Turkey	0.84%
Switzerland	0.09%
Canada	0.05%

Based on 1000 largest holdings

Jaguar Health, Inc. is a commercial-stage pharmaceuticals company. The Company is focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress. It operates through two segments: human health and animal health. The animal health segment is focused on developing and commercializing prescription and non-prescription products for companion and production animals. The human health segment is focused on developing and commercializing of human products and the ongoing commercialization of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) on antiretroviral therapy. The Canalevia-CA1 is for the treatment of chemotherapy-induced diarrhea (CID) in dogs. Its subsidiary Napo Pharmaceuticals, Inc. focuses on developing and commercializing human prescription pharmaceuticals.

Employees

Sector

Pharmaceuticals

Calendar

13/08 - Q2 2025 Earnings Release (Projected)

More about the company